You're viewing an archived page from a previous Festival of Ideas. See this year's festival »
This roundtable will debate pharmaceutical innovation in relation to clinical trial openness, patents and Intellectual Property from an inter-disciplinary perspective. It will examine marketing and business models, and explore some of the major challenges, as well as potential benefits, associated with different practices, legal frameworks and policies. Looking at the implications of all these themes on contemporary global health, it will adopt an international perspective with the help of a range of experts from Europe and the US.
Professor Stuart Blume, University of Amsterdam
Professor Nitsan Chorev, Brown University
Professor David Heymann, London School of Hygiene and Tropical Medicine
Dr Zafar Mirza, WHO
Chair: Professor Andrew Webster, University of York